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EXECUTIVE SUMMARY 
 
Abstract: The purpose of this study was to identify the association between ROTEM-guided 
therapy and chest tube output in patients who have undergone elective on-pump CABG. 
Introduction: In open heart surgery, there are a variety of ways that coagulation disturbances 
occur, such as hemodilution of coagulation factors and platelets, a reduction in coagulation 
factors due to the use of cardiopulmonary bypass the administration of the anticoagulant heparin, 
and altered temperature.  Severe bleeding is frequently associated with open-heart surgery, 
especially on-pump coronary artery bypass grafting (CABG). Thromboelastometry using 
rotational thromboelastometry (ROTEM) is a point-of-care testing that can show specific defects 
in the coagulation process and help guide the way the deficiencies are replaced. ROTEM uses a 
sample of patients’ blood and forms a clot, creating a graphic and numerical representation of the 
clotting process. 
Methodology: This study used a retrospective, quantitative, case-control design at Charleston 
Area Medical Center in West Virginia. A chart review was conducted on adult patients who 
underwent elective on-pump CABG from January 1, 2012 to June 1, 2016. A review of medical 
records was conducted on 200 patients at CAMC Memorial Hospital. The sample was grouped a 
ROTEM-guided therapy group (n=100) and non-ROTEM-guided therapy group (n=100). Patient 
characteristics of age, gender, race, and Body Mass Index (BMI) kg/m2 were collected. Clinical 
characteristics of cardiopulmonary bypass time (CPB) in minutes, number of bypasses, and chest 
tube output at 1 hour, 2 hours, 4 hours, and 8 hours measured in milliliters (ml) were collected. 
Means were compared using the Independent t-test for age, BMI, CPB, number of bypasses, 
chest tube output at 1 hour, at 2 hours, at 4 hours, and at 8 hours. Chi-square test was used to 
compare gender and race. A multiple step-wise linear regression was used to determine a 
relationship between chest tube output at 1, at 2, at 4, and at 8 hours with age, gender, race, BMI, 
CPB, and ROTEM-guided therapy (RGT). 
Results: There was no statistical significance found between the ROTEM-guided therapy and 
chest tube output at 1, 2, 4, or 8 hours. The mean age for the total sample was 58.5 years, mean 
number of bypasses 3.67, and mean BMI was 29.4. Of the 200 patients, 154 (76%) were male, 
46 (23%) were female.  Statistical significance was found in the RGT group and number of 
bypasses (p=0.027); and RGT and CPB (p<0.001).  A statistically significant association was 
also found between BMI and chest tube output 1 hour (p=0.001), at 2 hours (p=0.001), at 4 hours 
(p<0.001), and 8 hours (p<0.001).  
Discussion: This study found that as BMI increases with patients undergoing on-pump CABG 
was associated with decreased chest tube output. Though there was longer CPB time and slightly 
more bypasses conducted on patients who received ROTEM-guided therapy, the amount of chest 
tube output was not significant different than patients who did not receive ROTEM-guided 
therapy. The association between the independent variables age, gender, cardiopulmonary bypass 
time, and number of bypasses with chest tube output at each hour measured was not significant. 
The literature is conflicting on the efficacy of ROTEM with decreasing chest tube output but 
supports the findings of increased BMI with decreased chest tube output. Several limitations 
were identified and discussed. 
Conclusion: This study revealed there was no difference in chest tube output between the 
patients who received ROTEM-guided therapy and those who did not receive ROTEM-guided 
therapy. However, the study did reveal that increasing of BMI may lead to lower intraoperative 
blood loss. 
 v 
Implications/Recommendations: Improvements should continue to be made on point-of-care 
coagulation testing. Anesthesia practitioners may benefit from algorithms regarding ROTEM and  
continual assessment of practice and protocol may prove beneficial. 
 
Key Words: ROTEM, CABG, chest tube output, BMI 
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INTRODUCTION 
Background and Significance 
In open heart surgery, abnormalities of the coagulation system can be problematic. There 
are a variety of ways that coagulation disturbances occur, such as hemodilution of coagulation 
factors and platelets, a reduction in coagulation factors due to the use of cardiopulmonary bypass 
(CPB), the administration of the anticoagulant heparin, and altered temperature.  Severe bleeding 
is frequently associated with open-heart surgery, especially on-pump coronary artery bypass 
grafting (CABG). Surgery patients undergoing cardiovascular revascularization have some of the 
highest rates of blood product administration. Risk is associated with the administration of blood 
products. There is an inverse association between the amount of product transfused and patient 
outcomes.  
Thromboelastometry using rotational thromboelastometry (ROTEM) is a point-of-care 
testing that can show specific defects in the coagulation process and help guide the way the 
deficiencies are replaced. ROTEM uses a sample of patients’ blood and forms a clot, creating a 
graphic and numerical representation of the clotting process (Kroll, 2010). When ROTEM-
guided therapy is used, studies show there is a significant reduction in blood product 
administration in CABG patients (Ak et al., 2009; Deppe et al., 2016; Weber et al., 2012). While 
ROTEM is not a new technology, it is not widely utilized among anesthesia providers.  
Blood loss is a useful guide to coagulation status. In cardiovascular surgery, especially 
CABG, chest tubes are inserted to allow blood to drain into a collection device. The current 
literature has conflicting understanding of the role of ROTEM associated with cardiac surgery. 
The efficacy of the ROTEM testing and the therapy to follow being effective in some studies and 
not as effective in others. The current case-control study investigates the relationship between 
ROTEM-guided therapy and chest tube output in on-pump CABG patients.  
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Literature Review 
Blood product administration is not without risk. Most notably are complications 
regarding immune suppression and infection resulting in approximately $17 billion in annual 
cost (Murphy et al., 2007; Shander, Hofmann, Gombotz, Theusinger, & Spahn, 2007).   
In the United States, cardiovascular surgery accounts for 24% of transfused packed red blood 
cells (PRBC), 20% transfusion of platelets, and 34% transfusion of plasma (Cobain, Vamvakas, 
Wells, & Titlestad, 2007). To compare populations of surgeries relating to the abdomen are 17% 
PRBC, 19% platelets, and 26% plasma. Transfusion of PRBC, fresh frozen plasma (FFP), and 
platelets can lead to serious adverse outcomes such as associated with acute lung, renal failure, 
hypervolemia, neurologic events, and cardiac complications (Khan et al., 2007; Koch et al., 
2006; Spiess et al., 2004). Transfusion of PRBC has a strong association with infection; the more 
PRBCs transfused the higher the incidence of infection (Murphy et al., 2007).  
Bleeding in excess after cardiac surgery is often treated with administration of blood 
products, which increases the risk of re-exploration, resulting in morbidity and mortality (Koch 
et al., 2006; Murphy et al., 2007).  Identifying the characteristics of patients with a high risk for 
coagulopathies is critical, especially in cardiac surgery. From just one unit, a measurement of the 
amount of blood product in a container, of PRBC transfused the risk of mortality increases by 
77% and when the PRBC transfusions exceed 5 units, risk of death increased dramatically (Koch 
et al., 2006). The development of strategies to reduce the need for transfusion has been an 
ongoing concern and struggle for health care providers, especially in open-heart surgeries.  
In open-heart surgery, factors that effect a patient’s bleeding are heparin, 
cardiopulmonary bypass (CPB), hypothermia, type of open heart surgery, and other factors 
specific to the patient. High levels of the drug heparin are usually needed for CPB and are 
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monitored using an activated clotting time (ACT) test during the case (Mittermayr et al., 2005). 
Anticoagulation must be used during cardiac surgery to limit the chance of clot formation in the 
extracorporeal circuit of the CPB (Makar et al., 2010). As blood passes through cardiopulmonary 
bypass circuit it travels through plastic, non-endothelial surfaces, activating the clotting 
mechanism and thus the need for anticoagulant medications like heparin (Despotis et al., 1996). 
Heparin is used because it is effective and reversible with protamine (Ferraris et al., 2007). A 
lengthy time on CPB has been shown to increase the volume of chest tube drainage and to 
increase the likelihood of re-exploration (Despotis et al., 1996; Moulton, Creswell, Mackey, Cox, 
& Rosenbloom, 1996). While on CPB, excessive dilution of blood and coagulation factors can 
occur, diminishing oxygen carrying capacity, creating tissue acidosis, and extravascular fluid 
shifts (Daniel, 1996). Hypothermia, or lower temperatures of the patient, have also been 
associated with increasing chest tube drainage (Despotis et al., 1996). Valve surgeries also 
account for a larger amount of blood loss (Hardy et al., 1991; Moulton et al., 1996). 
Focusing on the patient factors associated with coagulopathies has been instrumental in 
the prediction of bleeding in cardiac surgery. In cardiac surgery, patients who had a high risk of 
coagulopathies were: age greater than 70 years, a low preoperative red blood cell count, 
preoperative antithrombotic or antiplatelet drugs, complex or re-exploration surgeries, 
emergency surgeries, and patient comorbidities such as bleeding disorders, diabetes, renal 
failure, and disease of the liver (Ferraris et al., 2007; Moulton et al., 1996). Patients in a higher 
risk group have a higher incidence for cardiac tamponade and re-exploration, resulting in a 
longer length of stay and an increase in morbidly and mortality (Čanádyová, Zmeko, & 
Mokráček, 2012).  Another study found that surgical re-exploration doubles the incidence of 
mortality (Ranucci et al., 2008). The more risk factors a patient has, the higher mortality after re-
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exploration (Kristensen, Rauer, Mortensen, & Kjeldsen, 2012). Thromboelastography has been 
shown to decrease the number of re-explorations, length of stay, and blood product 
administration (Spalding et al., 2007; Spiess, Gillies, Chandler, & Verrier, 1995). 
 Thromboelastography (TEG) has been available since 1948 where Hartert used the fibrin 
polymerization process and charted it as visualized graphical data (Hartert, 1948). TEG is 
classically known for having a sample of blood with a small cuvette slowly rotated to imitate 
venous flow and activate coagulation (Kroll, 2010). The process of using thrombelastography 
has advanced over the years, resulting in today’s technology of the thromboelastometry. 
Thromboelastometry is referred to more commonly by a brand name, ROTEM. ROTEM is 
slightly different as the cuvette is stationary and as the wire probe oscillates, a clot forms and 
impedes movements of the probe and measures several variables from the clot formation and 
lysis (Kroll, 2010). ROTEM minimizes susceptibility to mechanical variables, like shocks and 
vibrations to the equipment. This point-of-care testing can provide graphic and numerical 
representation of the coagulation proteases and inhibitors, the fibrinolytic system, and the sum of 
platelet function at bedside within 30 minutes (Luddington, 2005).  
Standard coagulation essays, plasma thromboplastic (PT) and partial thromboplastin 
(PTT), platelet count and fibrinogen concentrations are at times insufficient for monitoring 
coagulation when multiple factors affecting coagulation exist (Mallett & Cox, 1992). ROTEM 
has been proven to be a faster method in which to detect coagulopathies in cardiac patients in 
numerous studies.   
Clot evaluations with ROTEM measures these parameters as a 1) guide for transfusion of 
fresh frozen plasma (FFP), 2) the clot strength to assess platelet function, and 3) heparinase to 
assess protamine dosage requirement (Luddington, 2005). ROTEM assessments examine 
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coagulation either with an intrinsically activated test (INTEM) or an extrinsically activated test 
(EXTEM) (Lang et al., 2005). The fibrin-specific clot formation (FIBTEM) shows the 
assessment of fibrin levels without the interaction of platelets by the inhibition of the platelets 
using cytochalasin D (Ogawa et al., 2012). Under INTEM heparinase neutralization is tested 
(HEPTEM) to detect heparin and the effect heparin has on coagulation (Mittermayr et al., 2005).  
The predictive function of ROTEM analysis and blood loss as been studied well, as 
ROTEM is used in a variety of surgeries including cardiac, liver-transplantation, trauma and 
obstetrics (Kroll, 2010).  Transfusion and ROTEM algorithms that specify certain characteristics 
of the assessment and administration of blood products are usually research-based but vary from 
hospital to hospital. These algorithms have been shown to decrease the amount of blood products 
transfused (Ak et al., 2009; Deppe et al., 2016; Weber et al., 2012).  
ROTEM-guided therapy has been associated with saving half the cost of conventional 
management of coagulopathies (Weber et al., 2012). Due to the increase of morbidity associated 
with transfusion, which is dose dependent, ICU and postoperative hospital stays can increase, 
thereby increasing costs (Murphy et al., 2007). It was predicted in their study avoiding 
transfusions of PRBC could have a cost saving of 50%. In another study, implementation of 
ROTEM-guided therapy decreased the administration of PRBC by 25% and platelets 
administration by 50%, while also noting that overall after implementation of ROTEM-guided 
therapy there was a cost saving of over 40% (Spalding et al., 2007). 
Significance of the problem and Research Purpose 
Blood loss is a useful guide to coagulation status. In cardiovascular surgery, especially 
CABG, chest tubes are inserted to allow blood to drain into a collection device. This study 
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investigated the relationship between ROTEM-guided therapy and chest tube output in on-pump 
CABG patients.  Specific aims included: 
1. Expand upon the relationship between ROTEM-guided therapy and chest tube output. 
2. Identify the efficacy of ROTEM-guided therapy at CAMC. 
3. Compare the amount of blood loss, measured in chest tube output, in CABG surgery 
with ROTEM-guided therapy, measured in milliliters of chest tube drainage. 
 
METHODOLOGY 
Research Hypothesis 
The hypothesis of this study was that in adult patients aged 18-70 years with ASA physical 
classification status of III-IV who underwent elective CABG using ROTEM-guided therapy 
there would be less blood loss, measured in chest tube output, than patients who did not receive 
ROTEM-guided therapy. 
Research Design and Setting 
The design of this study is a retrospective case-control conducted at Charleston Area 
Medical Center (CAMC), Charleston, West Virginia. The case-control type of study was chosen 
due to the time constraint, ability to look at multiple risk factors, and control for confounding 
variables. 
Sample Population and Description of Sample 
The sample population included patients, who underwent elective on-pump CABG 
surgery at CAMC from January 1, 2012 to June 1, 2016. A review of medical records was 
conducted on 200 patients at CAMC Memorial Hospital. Two groups of 100 patients each were 
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established for comparison; a ROTEM-guided therapy group and non-ROTEM-guided therapy 
group. 
The subjects were identified by The International Classification of Diseases, 9th revision, 
Clinical Modification (ICD-9-CM) codes 36.1 (Bypass anastomosis for heart revascularization), 
36.2 (heart revascularization by arterial implant), 39.61 (cardiopulmonary bypass).  
The ICD-10-CM codes included coronary artery bypass for one, two, three, and four or 
more bypasses (Appendix A). 
Inclusion criteria:  
1. Male and female adult patients 18 to 70 years of age 
2. ASA physical status classification III-IV 
3. Underwent elective CABG and admitted to the CAMC Memorial Hospital cardiac ICU.  
Exclusion criteria:  
1. Emergent CABG surgery 
2. Valve surgeries 
3. Patients who underwent redo-CABG 
4. Patients who took direct oral anticoagulants (glycoprotein IIb.IIIa antagonist or 
clopidogrel) within 5 days of surgery and low-molecular weight heparin until the day of 
surgery 
5. Patients with diabetes mellitus, impaired renal function (creatinine greater than 2 mg/dL), 
and liver disease with elevated liver function tests (ALT greater than 56, AST greater 
than 40) 
Procedures and Protocol 
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A retrospective study was performed using patient information gathered from the CAMC 
EMR system for patients who underwent elective CABG using simple randomization of 2000 
charts. The sample consisted of 200 patients, 100 patients met the ROTEM-guided therapy 
guidelines, while the other 100 had no ROTEM assessment completed. Data was collected from 
the patients’ preoperative, intraoperative anesthesia record, perfusion records, and post 
anesthesia records. Data collected from the anesthesia records included: gender, race, age, 
height, weight, Body Mass Index (BMI), ASA physical status classification (Appendix B), length 
of CPB, and number of bypasses. Gender was classified as male or female. Age was measured in 
years. BMI is a calculation, measured in kg/m2, using height in meters and weight in kilograms 
to determine a person’s level of obesity. Length of CPB was measured in minutes. Measured 
chest tube output was recorded at 1, 2, 4, and 8 hours’ post admission to the cardiac ICU. Chest 
tube output was measured in milliliters.   
Placement in the ROTEM-guided therapy group (RGT) was determined if the patient had 
a ROTEM testing complete and reviewed by an anesthetist. 
Data Collection and Instrumentation 
Microsoft excel was used by the researchers to organize data collection. Each patient was 
given a number in the order in which the data was collected. The number was in no way linked 
the data collected to the patient it belongs to (Appendix C). 
Statistical Design and Analysis 
 The purpose of this study was to determine if there was less blood loss, measured in chest 
tube output in milliliters, between the elective on-pump CABG patient who received ROTEM-
guided therapy and those who did not (yes=1, no=0). The independent variable was ROTEM-
guided therapy and the dependent variables were chest tube output at 1, 2, 4, and 8 hours. 
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Control variables included in the regression are, BMI kg/m2, ASA physical status classification, 
race (white and non-white), gender (male=0, female =1), length of CPB (minutes), and number 
of bypasses. Stepwise regression was performed to estimate if there was an association between 
the amount of blood surgical loss and ROTEM-guided therapy. A t-test was conducted to 
determine any differences between the two groups in terms of age, body mass index, number of 
bypass, and length of cardiopulmonary bypass. Chi-squared test was employed to compare 
gender, race, and ASA. A p-value of <0.5 was considered statistically significant. 
Ethical Considerations 
This study was approved by the CAMC and West Virginia University-Charleston 
Division Institutional Review Board on June 30, 2017 (Appendix D). 
RESULTS 
Presentation, Analysis and Interpretation of Data 
 Patients were categorized into a non-ROTEM guided therapy group (NRGT – control 
group (n=100)) and were compared to patients in ROTEM-guided therapy group (RGT – case 
group (n=100)) (Table1). All patients were ASA physical status classification IV. There were 
154 male patients and 46 female patients. Male patients comprised of 75 in the NRGT and 79 in 
the RGT. Female patients comprise of 25 in the NRGT and 21 in the RGT. Of the sample 195 
patients identified as white and 5 patients identified as non-white. The NRGT had 97 patients 
identifying as white and 3 patients identified as non-white, while the RGT had 98 patients 
identifying as white and 2 non-white. The Chi-Square difference test was used to compare the 
distribution of gender and race between NRGT and RGT. Results revealed no significant 
difference in gender (p=0.502). Results revealed no significant difference in race (p=0.651). 
There is an equal split of gender and race between NRGT and RGT. 
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Table 1 also presents the results of the independent t-test analysis, displaying no 
significant difference in the mean age between the NRGT and the RGT (NRGT of 57.81 years 
versus RGT of 59.19 years; p= 0.163). There was also no difference in BMI between the NRGT 
and the RGT (NRGT of 29.047 kg/m2 versus RGT of 29.804 kg/m2; p= 0.344). However, with a 
p-value of less than 0.05 being significant, the number of bypasses was slightly greater in the 
ROTEM-guided therapy group than the non-ROTEM guided therapy group (NRGT of 3.51 
bypasses versus RGT of 3.83 bypasses; p= 0.027). CPB time was significantly different between 
non-ROTEM-guided therapy and the ROTEM-guided therapy group with the ROTEM-guided 
therapy group having a significantly longer time on bypass (NRGT 89.46 minutes versus RGT 
114.22 minutes p<0.001). 
 
  
Table 2 shows the results of the independent t-test analysis displaying the mean chest 
tube output for the NRGT and RGT at 1, 2, 4, and 8 hours. The chest tube output was measured 
Table 1: Demographic and Clinical Characteristics (n=200)  
Total Sample 
(n=200) 
NRGT 
(n=100) 
RGT 
(n=100) 
P-value 
Gender (%)    0.502 
Male 154 (76) 75 (37.5) 79 (39.5)  
Female 46 (23) 25 (12.5) 21 (10.5)  
Race (%)    0.651 
White 195 (97.5) 97 (48.5) 98 (49) 
 
Non-White 5 (2.5) 3 (1.5) 2 (1) 
 
Age (mean, SD) 58.5 ± 6.98 57.81 ± 7.035 59.19 ± 
6.899 
0.163 
BMI kg/m2 (mean, SD) 29.43 ± 5.64 29.047 ± 6.085 29.80 ± 
5.159 
0.344 
Number of Bypasses 
(mean, SD) 
3.67 ± 1.03 3.51 ± 0.959 3.83 ± 1.074 0.027 
CPB time (minutes) 
(mean, SD) 
101.84 ± 40.69 89.46 ± 36.244 114.22 ± 
41.288 
<0.001 
Formatted: Not Highlight
Formatted: Not Highlight
Formatted: Not Highlight
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in cumulative amounts not isolated hours. So, the first hour would have an effect upon the 
second and so on. The mean chest tube output at 1 hour with NRGT having 162.3 ml versus 
RGT having 150.9 ml (p=0.446). The mean chest tube output at 2 hours with NRGT having 
240.5 ml versus RGT having 226.7 ml (p=0.491). The mean chest tube output at 4 hours with 
NRGT having 366.2 ml versus RGT having 339.8 ml (p=0.381). The mean chest tube output at 8 
hours with NRGT having 531.6 ml versus RGT having 527.3 ml (p=0.925). There was no 
significant difference in the mean chest tube output between the NRGT and RGT at 1, 2, 4, and 8 
hours. However, in the RGT there was less each hour, just not statistically significant. 
 
 
Multiple step-wise linear regression was performed to estimate the association between 
the RGT status and the dependent variable, chest tube output at 1, 2, 4, and 8 hours while 
controlling for covariates (Table 3). This test revealed no statistical significance between the 
RGT status and the chest tube output variable but there was a significant association between 
BMI and each hour of measurement. Interestingly, for every increase in the BMI by 1 point, 
chest tube output decreased, and at increasing amounts at each measured hour. Chest tube output 
at hour 1 showed that for every 1 point BMI increased, chest tube output decreased by 4.28ml 
Table 2: Independent T-test on chest tube output at 1 hour, 2 hours, 4 hours, and 8 hours 
(n=200) 
 Group Mean Std. Deviation Std. Error Mean P-value 
Chest tube output 
(ml) at 1 hour 
NRGT (n=100) 162.3 105.3 10.5 
0.446 
RGT (n=100) 150.9 109.7 10.9 
Chest tube output 
(ml) at 2 hour 
NRGT (n=100) 240.5 141.7 14.2 
0.491 
RGT (n=100) 226.7 141.9 14.2 
Chest tube output 
(ml) at 4 hour 
NRGT (n=100) 366.2 225.9 22.6 
0.381 
RGT (n=100) 339.8 198.6 19.9 
Chest tube output 
(ml) at 8 hour 
NRGT (n=100) 531.6 337.5 33.8 
0.925 
RGT (n=100) 527.2 320.7 32.1 
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(p=0.001). At the “Chest tube output at 2 hour” measurement, it was shown that for every 1 point 
of increased BMI, chest tube output decreased by 5.79ml (p=0.001). At the 4th hour of chest tube 
output measurement, for every increase of BMI, a decrease of 10.03ml of chest tube output was 
seen (p<0.001). And finally, at the 8th hour of measurement, every BMI increase of 1 point 
showed a decrease of 16.91ml of chest tube output (p<0.001). 
 
Table 3: Results of Stepwise Linear Regression on Chest Tube Output 
Dependent 
Variable Model 1 
Unstandardized 
coefficients 
Standard 
Coefficients 
  
B Std Error Beta t 
P-
value 
Chest tube output 
(ml) at 1 hour 
Constant 282.529 39.499  7.153 <0.001 
BMI -4.283 1.318 -0.225 -3.24 0.001 
Chest tube output 
(ml) at 2 hour 
Constant 404.121 52.021  7.768 <0.001 
BMI -5.795 1.736 -0.231 -3.337 0.001 
Chest tube output 
(ml) at 4 hour 
Constant 648.089 77.346  8.379 <0.001 
BMI -10.029 2.582 -0.0266 -3.884 <0.001 
Chest tube output 
(ml) at 8 hour 
Constant 1027.083 118.616  8.659 <0.001 
BMI -16.913 3.959 -0.290 -4.272 <0.001 
 
DISCUSSION 
Discussion of Study Results 
This current study found no significantly decreased chest tube output in elective CABG 
patients between patients who did or did not received ROTEM-guided therapy. The RGT group 
did not have a statistically different chest tube output compared to the NRGT group. However, as 
shown in table 3, the RGT group did have slightly more bypasses than the NRGT group and 
significantly longer CPB time. This can be interpreted in two ways: (1) Even though with more 
bypasses and longer CPB, the RGT maintained the same amount of chest tube output as the 
group with less bypasses; or (2) the RGT does not alter blood loss because the chest tube output 
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is approximately the same. With each bypass comes the risk of bleeding so maintaining close to 
same amount of chest tube output comparatively may be a sign of success of control of excessive 
blood loss. 
This study finding that while at each interval, the RGT group had less blood loss than the 
NRGT, the amount of chest tube output was not significantly different between the two groups, 
is not line with prior studies. A prospective study of elective cardiac surgeries identifying the use 
of a simple ROTEM based algorithm compared to a control non-algorithm showed a significant 
decrease in postoperative blood loss at 4 hours, 12 hours, and 24 hours (Nuttall et al., 2001). In 
another prospective study by Weber, et al., there was a significant decrease in chest tube output 
at 6, 12, and 24 hours between a conventional group and ROTEM group. However, it must be 
noted that these studies included aortic, CABG, redo, and valve surgeries, which each surgery 
may have different amounts of bleeding typically seen. In another study of only aortic surgeries 
with high-risk cardiac patients, chest tube output was notably similar between the ROTEM and 
control group at 12 and 24 hours (Girdauskas et al., 2010). The study control variables may play 
a role in governing the relationship between variable as they are different from these other 
studies. There continues to be a differing of opinion on usage of ROTEM and the efficacy of 
thromboelastography as a point of care assessment of coagulation. 
CPB has been shown to have a great influence on postoperative hemorrhage in the 
literature, with the increase of CPB time increasing the chance of hemorrhage in most studies 
(Christensen, Krapf, Kempel, & von Heymann, 2009). However, CPB in the present study was 
not associated with an increase in bleeding. In regards to the longer time on bypass, this factor 
may indicate that the patient had a higher chance of bleeding and trigger the anesthetist to obtain 
Formatted: Not Highlight
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a ROTEM and correct the deficiencies. This could also account for the chest tube output 
similarities as well. 
 There was a greater frequency of male subjects (76%) to female subjects (23%) in the 
sample with 97.5% of the sample being white. However, this is similar to a meta-analysis which 
had 93.4% male subjects white, and 91% of female subjects white; 70.3% of the subjects were 
male and 29.7% were female (Vaccarino, Abramson, Veledar, & Weintraub, 2002). The smaller 
percentage of female gender may be due to the association with increased morbidity and 
mortality to CABG than the male gender and with better outcomes being noted with off-pump 
CABG in the female gender. (Brown et al., 2002). With off-pump CABG being utilized this 
would account for the decrease in female gender in the sample in this study. In this study gender 
and race did not have an association with chest tube output. 
This study finding that an association was found between chest tube output and the 
independent variable of BMI is consistent with previous studies, indicating that an increase in 
patient weight has an effect on blood loss. Patients with a smaller BMI, less than 25 kg/m2, have 
a higher risk for bleeding and are at risk for re-exploration due to the bleeding (Karthik, Grayson, 
McCarron, Pullan, & Desmond, 2004). A recent study shows that for every increase in kilogram 
of weight there is a decreased risk of transfusion. (Mazlan, Ayob, Hussein, Namasiwayam, & 
Wan Mohammad, 2017). The increase of a BMI with decrease of a chest tube output aids in 
support of this predictable model. 
Study Limitations 
 There are multiple limitations to acknowledge in this study. First, the study design was 
retrospective, so selection bias cannot be ruled out. The sample size may not have been adequate 
due to the design, and no use of a power analysis. Increasing the sample size may have an impact 
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on the study. In addition, the present study has no ability to estimate causality between variables. 
A longitudinal study design would correctly investigate casual relationship. 
 The present study used convenient sampling technique thereby the study findings are 
limited to CAMC patients, not representing WV or the national level.  
 This study compares the non-ROTEM-guided therapy to the use of ROTEM-guided 
therapy in on pump, elective CABG. This sample of data essentially compared one particular 
portion of the practice of two different anesthesiologists. Comparing the results between a 
ROTEM-guided and non-ROTEM-guided group taking into consideration the practice of all 
cardiovascular anesthesiologists at CAMC may prove more beneficial.  
 Another potential caveat is documentation error by various clinicians. An error in 
documentation could lead to inappropriate inclusion or exclusion of subjects. There may be 
inconsistencies in measuring, such as rounding and transcription error. Using a retrospective 
design, the data could be misinterpreted, misread, or there could be improper documentation.  
 Several factors outside of the assessment of thromboelastography can contribute to 
postoperative chest tube output, including but not limited to; medications, hypothermia, acidosis, 
and surgery-related causes. 
CONCLUSIONS 
This study revealed there was no difference in chest tube output between the patients who 
received ROTEM-guided therapy and those who did not receive ROTEM-guided therapy. With a 
significantly longer time on cardiopulmonary bypass and slightly more bypasses in the ROTEM-
guided therapy group, ROTEM should be considered as an effective and beneficial intervention. 
However, the study did reveal that increasing of BMI may lead to lower intraoperative blood 
Formatted: Not Highlight
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loss. This may seem unreasonable to manipulate clinically and may not be a clinically significant 
amount; however, it is still worth noting.  
IMPLICATIONS AND RECOMMENDATIONS 
Assessment of bleeding and implementation of the transfusion of blood products are 
integral components to the success of CABG patients. Therefore, it is imperative to improve 
methods on the conversation of blood loss. This study does not provide statistically significant 
clinical evidence of a relationship between RGT and decreasing chest tube output in elective on-
pump CABG patients. RGT was only measured by each anesthetist’s application and parameters 
of practice. A guideline is available for the anesthetist in the facility; however, following the 
guideline was upon the anesthetist’s purview. Having an algorithm for assessment and 
transfusion may provide benefit for the anesthetist with less experience using RGT. Algorithms 
have been shown useful in previous studies with success, and routinely updating the algorithms 
would also be beneficial. To improve upon this study, measuring the amount and type of blood 
products administered to each group might also be advantageous rather than chest tube output 
alone.  
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APPENDICES 
Appendix A 
One Coronary Bypass: 0210093 (Bypass Coronary Artery, One Artery from Coronary 
Artery with Autologous Venous Tissue, Open Approach), 0210098 (Bypass Coronary Artery, 
One Artery from Right Internal Mammary with Autologous Venous Tissue, Open Approach), 
0210099 (Bypass Coronary Artery, One Artery from Left Internal Mammary with Autologous 
Venous Tissue, Open Approach), 021009C (Bypass Coronary Artery, One Artery from Thoracic 
Artery with Autologous Venous Tissue, Open Approach), 021009W (Bypass Coronary Artery, 
One Artery from Aorta with Autologous Venous Tissue, Open Approach), 02100A3 (Bypass 
Coronary Artery, One Artery from Coronary Artery with Autologous Arterial Tissue, Open 
Approach), 02100A8 (Bypass Coronary Artery, One Artery from Right Internal Mammary with 
Autologous Arterial Tissue, Open Approach), 02100A9 (Bypass Coronary Artery, One Artery 
from Left Internal Mammary with Autologous Arterial Tissue, Open Approach), 02100AC 
(Bypass Coronary Artery, One Artery from Thoracic Artery with Autologous Arterial Tissue, 
Open Approach), 02100AF (Bypass Coronary Artery, One Artery from Abdominal Artery with 
Autologous Arterial Tissue, Open Approach), 02100AW (Bypass Coronary Artery, One Artery 
from Aorta with Autologous Arterial Tissue, Open Approach), 
Two Coronary Bypass: 0211093 (Bypass Coronary Artery, Two Arteries from Coronary 
Artery with Autologous Venous Tissue, Open Approach), 0211098 (Bypass Coronary Artery, 
Two Arteries from Right Internal Mammary with Autologous Venous Tissue, Open Approach), 
0211099 (Bypass Coronary Artery, Two Arteries from Left Internal Mammary with Autologous 
Venous Tissue, Open Approach), 021109C (Bypass Coronary Artery, Two Arteries from 
Thoracic Artery with Autologous Venous Tissue, Open Approach), 021109W (Bypass Coronary 
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Artery, Two Arteries from Aorta with Autologous Venous Tissue, Open Approach), 02110A3 
(Bypass Coronary Artery, Two Arteries from Coronary Artery with Autologous Arterial Tissue, 
Open Approach), 02110A8 (Bypass Coronary Artery, Two Arteries from Right Internal 
Mammary with Autologous Arterial Tissue, Open Approach), 02110A9 (Bypass Coronary 
Artery, Two Arteries from Left Internal Mammary with Autologous Arterial Tissue, Open 
Approach), 02110AC (Bypass Coronary Artery, Two Arteries from Thoracic Artery with 
Autologous Arterial Tissue, Open Approach), 02110AF (Bypass Coronary Artery, Two Arteries 
from Abdominal Artery with Autologous Arterial Tissue, Open Approach), 02110AW (Bypass 
Coronary Artery, Two Arteries from Aorta with Autologous Arterial Tissue, Open Approach) 
Three Coronary Bypass: 0212093 (Bypass Coronary Artery, Three Arteries from 
Coronary Artery with Autologous Venous Tissue, Open Approach), 0212098 (Bypass Coronary 
Artery, Three Arteries from Right Internal Mammary with Autologous Venous Tissue, Open 
Approach), 0212099 (Bypass Coronary Artery, Three Arteries from Left Internal Mammary with 
Autologous Venous Tissue, Open Approach), 021209C (Bypass Coronary Artery, Three Arteries 
from Thoracic Artery with Autologous Venous Tissue, Open Approach), 021209F (Bypass 
Coronary Artery, 021209W (Bypass Coronary Artery, Three Arteries from Aorta with 
Autologous Venous Tissue, Open Approach), 02120A3 (Bypass Coronary Artery, Three Arteries 
from Coronary Artery with Autologous Arterial Tissue, Open Approach), 02120A8 (Bypass 
Coronary Artery, Three Arteries from Right Internal Mammary with Autologous Arterial Tissue, 
Open Approach), 02120A9 (Bypass Coronary Artery, Three Arteries from Left Internal 
Mammary with Autologous Arterial Tissue, Open Approach), 02120AC (Bypass Coronary 
Artery, Three Arteries from Thoracic Artery with Autologous Arterial Tissue, Open Approach), 
02120AF (Bypass Coronary Artery, Three Arteries from Abdominal Artery with Autologous 
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Arterial Tissue, Open Approach), 02120AW (Bypass Coronary Artery, Three Arteries from 
Aorta with Autologous Arterial Tissue, Open Approach) 
Four or more Coronary Bypass: 0213093 (Bypass Coronary Artery, Four or More 
Arteries from Coronary Artery with Autologous Venous Tissue, Open Approach), 0213098 
(Bypass Coronary Artery, Four or More Arteries from Right Internal Mammary with Autologous 
Venous Tissue, Open Approach), 0213099 (Bypass Coronary Artery, Four or More Arteries 
from Left Internal Mammary with Autologous Venous Tissue, Open Approach), 021309C 
(Bypass Coronary Artery, Four or More Arteries from Thoracic Artery with Autologous Venous 
Tissue, Open Approach), 021309F (Bypass Coronary Artery, Four or More Arteries from 
Abdominal Artery with Autologous Venous Tissue, Open Approach), 021309W (Bypass 
Coronary Artery, Four or More Arteries from Aorta with Autologous Venous Tissue, Open 
Approach), 02130A3 Bypass Coronary Artery, Four or More Arteries from Coronary Artery with 
Autologous Arterial Tissue, Open Approach), 02130A8 (Bypass Coronary Artery, Four or More 
Arteries from Right Internal Mammary with Autologous Arterial Tissue, Open Approach), 
02130A9 (Bypass Coronary Artery, Four or More Arteries from Left Internal Mammary with 
Autologous Arterial Tissue, Open Approach), 02130AC (Bypass Coronary Artery, Four or More 
Arteries from Thoracic Artery with Autologous Arterial Tissue, Open Approach), 02130AW 
(Bypass Coronary Artery, Four or More Arteries from Aorta with Autologous Arterial Tissue, 
Open Approach) 
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Appendix B 
The ASA classification is a numeric scale developed by the American Society of 
Anesthesiologists to determine the general health of the patient. The classifications are: 
I. A normal patient who is health. 
II. A patient with mild systemic disease. 
III. A patient with severe systemic disease. 
IV. A patient with a severe systemic disease that is a constant threat to life. 
V. A moribund patient who is not expected to survive without surgery. 
VI. A brain-dead patient whose organ are being removed for transplant donation. 
(Anesthesiologists, 2017) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 26 
Appendix C 
 
 
 
 
 
 
 
 
 
 
 
Study Num
ber 
Age (years) 
BM
I (kg/m
2) 
ASA 
Race 
Gender (M
ale=0, 
fem
ale=1) 
ROTEM
‐guided 
therapy (0=no, 1=yes) 
Cardiopulm
onary 
bypass tim
e (m
inutes) 
Num
ber of Bypass 
Chest tube at 1 hour 
(m
l) 
Chest tube at 2 hour 
(m
l) 
Chest tube at 4 hour 
(m
l) 
Chest tube at 8 hour 
(m
l) 
1 
            
2 
            
3 
            
4 
            
5 
            
6 
            
7 
            
8 
            
9 
            
10 
            
11 
            
12 
            
13 
            
14 
            
15 
            
16 
            
17 
            
18 
            
19 
            
20             
 27 
Appendix D 
 
IRB Approval Form
 
